You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Chlortetracycline hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for chlortetracycline hydrochloride and what is the scope of freedom to operate?

Chlortetracycline hydrochloride is the generic ingredient in one branded drug marketed by Lederle and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for chlortetracycline hydrochloride.

Summary for chlortetracycline hydrochloride
Recent Clinical Trials for chlortetracycline hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of LouisvilleEarly Phase 1
James Graham Brown Cancer CenterEarly Phase 1
Julio RamirezEarly Phase 1

See all chlortetracycline hydrochloride clinical trials

Medical Subject Heading (MeSH) Categories for chlortetracycline hydrochloride

US Patents and Regulatory Information for chlortetracycline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle AUREOMYCIN chlortetracycline hydrochloride OINTMENT;OPHTHALMIC 050404-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Chlortetracycline hydrochloride Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Chlortetracycline Hydrochloride

Introduction to Chlortetracycline Hydrochloride

Chlortetracycline hydrochloride, commonly known by its trade name 'Aureomycin', is a tetracycline antibiotic isolated from Streptomyces aureofaciens. It is widely used as an antiprotozoal and antibacterial agent, particularly in the veterinary sector for treating various infections in livestock, poultry, and other animals[5].

Market Overview

The global chlortetracycline hydrochloride market has been experiencing significant growth, driven by several key factors.

Market Size and Forecast

The market is anticipated to reach substantial values over the forecast period. For instance, the global chlortetracycline market is expected to reach USD 296 million by 2027, with a Compound Annual Growth Rate (CAGR) of 13.1% from 2019 to 2027[5].

Segmentation

The market is segmented based on type (human use and veterinary use) and application (hospital, clinic, and other). Geographically, it is divided into regions such as North America, Europe, Asia-Pacific, South America, and the Middle East and Africa[1].

Market Dynamics

Drivers

  • Increasing Demand for Animal Products: The rising demand for animal products, particularly in the animal husbandry and poultry sectors, is a significant driver. This demand is fueled by growing populations and increasing consumption of meat and dairy products[5].
  • Prevalence of Animal Infections: The increasing occurrence of infections in animals necessitates the use of antibiotics like chlortetracycline hydrochloride, thereby driving market growth[5].
  • Growth and Feeding Efficiency: Chlortetracycline hydrochloride is used to improve growth and feeding efficiency in animals, which is another driving factor[5].

Restraints

  • Adverse Health Effects: The use of chlortetracycline hydrochloride can have adverse health effects on animals, such as inhibiting tooth and bone mineralization in growing animals and causing liver and kidney impairments. These factors may restrain market growth[5].
  • Regulatory Challenges: Strict regulations and concerns about antibiotic resistance can also act as restraints to the market[5].

Opportunities

  • Emerging Markets: Regions like Asia-Pacific, particularly countries such as India and China, offer significant opportunities due to their growing demand for antibiotics in the poultry industry[5].
  • Expanding Pet and Livestock Ownership: The increasing number of pet owners and livestock in major economies is expected to expand the market[5].

Challenges

  • Antibiotic Resistance: The growing concern about antibiotic resistance poses a challenge to the market. This could lead to reduced usage and stricter regulatory measures[5].
  • Alternative Treatments: The development of alternative treatments and the push for more sustainable and safer veterinary practices could also challenge the market[5].

Geographical Analysis

Asia-Pacific

This region is expected to account for the largest market share and is projected to grow steadily. The growing presence of key players, combined with a rise in demand for antibiotics in the poultry industry of emerging economies like India and China, contributes to this growth[5].

North America and Europe

These regions are also expected to contribute significantly to the market revenue, driven by factors such as rising disposable income, increasing demand for animal feed, and growing awareness about animal health[5].

Latin America, Africa, and Middle East

These regions are expected to show potential growth due to rising industrialization and economic progress, particularly in GCC countries[5].

Competitive Landscape

The global chlortetracycline hydrochloride market is competitive, with several key players:

  • Hebei New Century Pharmaceutical Co., Ltd.
  • Zoetis Inc.
  • Weifang Union Biochemistry Co., Ltd.
  • Qingdao Dacon Trading Co., Ltd.
  • Jiaxing Suns Intl Trade Co., Ltd.[5]

These companies are engaged in expanding their market presence through various strategies such as new product launches, collaborations, and mergers and acquisitions[1].

Financial Trajectory

Revenue Projections

The market is anticipated to achieve significant revenue growth. For example, the global chlortetracycline market is projected to reach USD 296 million by 2027, indicating a robust financial trajectory[5].

CAGR

The market is expected to register a CAGR of 13.1% over the forecast period, reflecting strong growth prospects[5].

Market Value Segmentation

The market value is segmented based on type, application, and geography. The veterinary use segment is expected to dominate due to the widespread use of chlortetracycline hydrochloride in animal health[1].

Key Takeaways

  • The global chlortetracycline hydrochloride market is driven by increasing demand for animal products and the prevalence of animal infections.
  • The market faces restraints such as adverse health effects and regulatory challenges.
  • Emerging markets, particularly in Asia-Pacific, offer significant growth opportunities.
  • The competitive landscape is dominated by key players who are expanding their market presence through various strategies.
  • The market is expected to achieve substantial revenue growth with a high CAGR.

Frequently Asked Questions

1. What is the expected market size of the global chlortetracycline market by 2027? The global chlortetracycline market is expected to reach USD 296 million by 2027[5].

2. What is the CAGR of the global chlortetracycline market from 2019 to 2027? The market is expected to register a CAGR of 13.1% over the forecast period[5].

3. What are the primary drivers of the chlortetracycline hydrochloride market? The primary drivers include increasing demand for animal products and the prevalence of animal infections[5].

4. Which region is expected to account for the largest market share in the chlortetracycline hydrochloride market? The Asia-Pacific region is expected to account for the largest market share[5].

5. What are some of the adverse health effects associated with the use of chlortetracycline hydrochloride in animals? Adverse health effects include inhibiting tooth and bone mineralization in growing animals and causing liver and kidney impairments[5].

Cited Sources

  1. Market Research Intellect, "Chlortetracycline Hydrochloride Market Size, Scope And Forecast", November 2024.
  2. Enzo Biochem, "Chlortetracycline hydrochloride".
  3. Market Research Report, "Chlortetracycline Hydrochloride Market Report".
  4. Business Research Insights, "Minocycline Hydrochloride Market Size, Trends, Report, 2032".
  5. Coherent Market Insights, "Chlortetracycline Market Size, Trends And Forecast To 2028".

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.